Circulating Tumor Cells Market to accumulate $2200 Mn by 2024

September 25, 2019

As per the latest study available with Market Study Report LLC under the title ‘Global Circulating Tumor Cells Market Growth (Status and Outlook) 2019-2024’, the worldwide circulating tumor cells market is expected to amass US $2200 million by the year 2024.

Circulating tumor cells or CTCs are cells which have entered the lymphatics or vasculature after detaching from the tumor and are circulating around the body. They are present in very low concentration in the bloodstream.

With evolution of technology, CTC counting is gaining attention as more research is happening and more data is gathered which helps in monitoring disease progression and provides guidance in personalizing cancer therapy. Surging incidences of cancer/tumor around the globe, technological advancements, and inflowing investments towards R&D activities are few factors propelling the growth of circulating tumor cells market.

According to the study, the global CTC market was worth US $730 million in 2019 and is anticipated to grow with a CAGR of 20.1% over the projected timeframe. The study also provides a comprehensive insight regarding the trends, challenges, opportunities, and drivers impacting the market growth.

The CTC market is studied as per different segmentations such as product type, application spectrum, and regional landscape. Based on product type, the market is bifurcated into CTC detection and CTC enrichment. While on the basis of application spectrum, the market is fragmented as breast cancer, lung cancer, colorectal cancer, prostate cancer, and other.

Speaking of regional landscape, the market in segmented as Americas, Middle East & Africa, Asia Pacific, and Europe. The United States CTC market held 47.41% revenue share in 2017, followed by Europe which contributed 26.24% share in the same year.

Request sample copy of this Report

Moreover, Asia Pacific CTC market is presumed to witness substantial growth over the forecast timeline, owing to the presence of motivated vendors in the nations like India and China who are focusing on improving their sales and expanding their distribution channels.

The major players of circulating tumor cells market profiled in the study are Menarini-Silicon Biosystems, ANGLE plc, Qiagen (Adnagen), Clearbridge Biomedics, Advanced Cell Diagnostics, Celsee, ApoCell, Guangzhou Wondfo Biotech, Epic Sciences, CytoTrack, Greiner Bio-one GmbH, and Biocept among others.